Abstract

WHEN a drug is given by intravenous infusion it is not possible to define its lethal dose if it is detoxified rapidly, because the apparent lethal dose will depend on the rate of administration of the drug. This difficulty has been emphasized by Beccari1, who pointed out that in the case of drugs which are rapidly eliminated it is better to define a ‘lethal rate’ of infusion rather than a lethal dose. The problem of deciding at which rate of infusion to determine the lethal dose has always been apparent in the study of cardiac glycosides, and has been accentuated by the earlier need for biological assay of these drugs. The relationship between rate of infusion and lethal dose of cardiac glycosides and aglycones is complex, depending both on the individual drugs and the species used for the determination of toxicity. In the British Pharmacopœia (1958) and the U.S. Pharmacopœia (thirteenth revision) this problem is defined by laying down maximum and minimum times during which each determination of lethal dose must be made. From Table 1 it can be seen that the apparent lethal dose of digoxigenin determined in the guinea pig depends on the time taken to produce death. At the lower rates of infusion in which the time to produce death is prolonged, the apparent lethal dose has the highest values.

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.